✓ Last verified: January 22, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Greenbrook TMS Mission Valley is centrally located in San Diego’s Mission Valley neighborhood on Frazee Road, offering insurance-covered Spravato (esketamine nasal spray) and NeuroStar TMS therapy. This location serves patients from central San Diego, Mission Hills, Hillcrest, North Park, and Kensington with FDA-approved treatments for treatment-resistant depression and MDD with suicidal ideation. As one of two Greenbrook locations in the San Diego metro, it provides a convenient central option for patients seeking insurance-covered ketamine-based treatment.
| Google Reviews | ⭐ 4.5 (National Network) |
| Location | San Diego, California |
| Address | 1450 Frazee Road, Suite 210, San Diego, CA 92108 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | Spravato (Esketamine Nasal Spray), NeuroStar TMS Therapy |
| Conditions Treated | Treatment-Resistant Depression, MDD with Suicidal Ideation |
| Cost | Covered by most major insurance plans |
| Insurance | Most major insurance accepted for both Spravato and TMS |
| KAP Available | No — Spravato administered under medical supervision (not KAP) |
| Clinical Lead | Greenbrook TMS Clinical Team |
HealingMaps Take: Mission Valley’s central location makes this Greenbrook office one of the most accessible in San Diego, with easy freeway access from nearly any part of the city. For patients who need insurance-covered Spravato treatment, having two San Diego Greenbrook locations (this one and Shoreham) means more scheduling flexibility and shorter wait times. The Mission Valley office is ideal for patients in the urban core of San Diego who want to combine treatment visits with other errands in this commercial hub.
Market Position: Greenbrook TMS (Mission Valley) is a Spravato-certified clinic in the Diego metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
Industry pricing reference. Greenbrook TMS (Mission Valley)’s posted price: Covered by most major insurance plans. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions Greenbrook TMS (Mission Valley) treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Greenbrook TMS (Mission Valley) offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Greenbrook TMS (Mission Valley) treats depression via Spravato (FDA-cleared for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
TMS therapy is also available at this clinic, alongside ketamine and Spravato. Unlike cash-pay ketamine, TMS is covered by most major insurance plans for treatment-resistant depression. TMS is FDA-cleared for treatment-resistant depression (since 2008), OCD via Deep TMS, anxious depression, and adolescent MDD ages 15–21. This clinic uses BrainsWay Deep TMS, the only TMS device with standalone FDA clearance for OCD via the H7 coil. Read our complete guide to TMS therapy for FDA-cleared conditions, device differences, insurance coverage by carrier, and what to expect at your first appointment. Browse verified TMS clinics in our directory.
View all REMS-certified Spravato clinics in California and across the United States.
Leave a Reply